SCHEMBL29644467

SCHEMBL29644467

CCC(=O)N1CC2(CCNCC2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.57
AKT1 P31749 6/20 0.52
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
BIRC2 Q13490 4/20 0.45
XIAP P98170 3/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
P2RY1 P47900 1/20 0.41
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543338 1.00 NOTUM (0.57) NOTUMAKT1ROCK2ROCK1BIRC2
SCHEMBL9047131 0.88 NOTUM (0.53) NOTUMAKT1ROCK2ROCK1BIRC2
SCHEMBL6543796 0.86 NOTUM (0.54) NOTUMAKT1ROCK2ROCK1BIRC2
SCHEMBL1572534 0.86 NOTUM (0.63) NOTUMAKT1ROCK2ROCK1HDAC1
SCHEMBL30232786 0.86 NOTUM (0.63) NOTUMAKT1ROCK2ROCK1HDAC1
SCHEMBL655024 0.85 NOTUM (0.80) NOTUMAKT1ROCK2ROCK1HDAC1
SCHEMBL6543487 0.84 NOTUM (0.55) NOTUMAKT1ROCK2ROCK1HDAC1
SCHEMBL1713780 0.84 NOTUM (0.57) NOTUMAKT1ROCK2ROCK1BIRC2
Hydrochloric Acid SCHEMBL2257588 0.83 NOTUM (0.78) NOTUMAKT1ROCK2ROCK1HDAC1
SCHEMBL6543320 0.81 NOTUM (0.57) NOTUMAKT1ROCK2ROCK1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114591327-B Indoline piperidine urea TRPV1 antagonism and MOR agonism double-target-point medicine, preparation method and application 河南大学 2023-02-07 CN disclosed
CN-114591327-A Indoline piperidine urea type TRPV1 antagonistic and MOR agonistic double-target-point medicine, preparation method and application 河南大学 2022-06-07 CN disclosed